Vote No. 254
Motion by Ms. Shalala to report the rule. Adopted: 6–3
Vote No. 253
Motion by Mrs. Lesko to amend the rule to H.R. 2339 to make in order amendment #12, offered by Rep. Griffith (VA), which amends the bill to include a prohibition against flavored marijuana products, stating that such products shall be treated in the same manner as flavored tobacco products. Defeated: 3–6
Vote No. 252
Motion by Mr. Woodall to amend the rule to H.R. 2339 to make in order amendment #7, offered by Rep. Burgess (TX), which strikes the increase in user fees for fiscal year 2021 unless the FDA submits to Congress the appropriate reports required under the Family Smoking Prevention and Tobacco Control Act. Defeated: 3–6
Vote No. 251
Motion by Mr. Woodall to amend the rule to H.R. 2339 to make in order amendment #14, offered by Rep. Walden (OR), which requires FDA to consider whether the denial of a marketing application for a flavored ENDS product will increase the likelihood that consumers will purchase illegal and adulterated products through the black market when determining whether a flavored product is less harmful than an unflavored ENDS product. Defeated: 3–6
Chairman McGovern, Ranking Member Cole Announce Rules Committee Hearing Examining Ways to Reassert Congress’ Constitutional Authority
Follows decades of Executive Branch encroachment on Congress’ constitutional role over matters like national emergencies, foreign policy, rulemaking, government funding and our military’s role abroad
Hearing Announcement on Article I: Constitutional Perspectives on the Responsibility and Authority of the Legislative Branch
The Committee on Rules will meet on Tuesday, March 3, 2020 at 10:00 AM in H-313, The Capitol on the following:
- Article I: Constitutional Perspectives on the Responsibility and Authority of the Legislative Branch [Original Jurisdiction Hearing]
**PLEASE NOTE: Witnesses for this hearing will be by invitation only.